FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 294:517-522 March 4, 1976 Number 10 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

To assess placental and fetoplacental function, 50 mg of dehydroepiandrosterone sulfate was administered intravenously to 11 normal obstetric patients at 35 to 40 weeks and to 36 high-risk patients at 35 to 43 weeks of pregnancy. Plasma estradiol converted from dehydroepiandrosterone sulfate by the placenta increased in all patients after infusion, with maximal concentrations of 28 to 65 ng per milliliter 30 to 60 minutes after infusion (P less than 0.01). Plasma estetrol, produced by the fetus from estradiol, increased in all patients with maximal concentrations of 0.8 to 3.2 ng per milliliter four hours after infusion (P less than 0.01). In complicated pregnancies a subnormal rise of estradiol and estetrol was highly suggestive of fetal distress whereas a normal rise was associated with no fetal distress. The simultaneous determination of estradiol and estetrol after dehydroepiandrosterone sulfate infusion may reflect placental and fetoplacental function, and may be used as an adjunct to other methods of assessing fetal well-being.

This article has been cited by other articles:

• Reis, F. M., D'Antona, D., Petraglia, F. (2002). Predictive Value of Hormone Measurements in Maternal and Fetal Complications of Pregnancy. Endocr. Rev. 23: 230-257 [Abstract] [Full Text]  
• Manabe, A., Hata, T., Yanagihara, T., Hashimoto, M., Yamada, Y., Irikoma, S., Aoki, S., Masumura, S., Miyazaki, K. (1999). Nitric oxide synthesis is increased after dehydroepiandrosterone sulphate administration in term human pregnancy. Hum Reprod 14: 2116-2119 [Abstract] [Full Text]